Skip to main content
Bicara Therapeutics Inc. logo

Bicara Therapeutics Inc. — Investor Relations & Filings

Ticker · BCAX ISIN · US0554771032 US Manufacturing
Filings indexed 169 across all filing types
Latest filing 2025-10-10 Director's Dealing
Country US United States of America
Listing US BCAX

About Bicara Therapeutics Inc.

https://www.bicara.com/

Bicara Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing first-in-class, dual-action biologics for cancer treatment. The company engineers bifunctional therapies that combine the precision of targeted treatments with the activation of a potent and durable anti-tumor immune response. This approach is designed to deliver therapeutic impact directly within the tumor microenvironment, with a primary focus on developing treatments for patients with solid tumors.

Recent filings

Filing Released Lang Actions
FORM 4
Director's Dealing
2025-10-10 English
Regulatory Filings 2025
Regulatory Filings
2025-10-09 English
Regulatory Filings 2025
Regulatory Filings
2025-10-09 English
FORM 4
Director's Dealing
2025-10-08 English
FORM 4
Director's Dealing
2025-10-08 English
Regulatory Filings 2025
Regulatory Filings
2025-10-08 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.